The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma

Abstract Background Inflammation and the immune system significantly impact the development, progression, and treatment response of hepatocellular carcinoma (HCC). This retrospective study investigated the neutrophil‐to‐lymphocyte ratio (NLR) as a prognostic biomarker in Western patients with HCC in...

Full description

Bibliographic Details
Main Authors: Cortlandt M. Sellers, Johannes Uhlig, Johannes M. Ludwig, Jeffrey S. Pollak, Tamar H. Taddei, Stacey M. Stein, Joseph K. Lim, Hyun S. Kim
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.3573
id doaj-ebeddeb203ff408e9028b0dd753e1503
record_format Article
spelling doaj-ebeddeb203ff408e9028b0dd753e15032021-08-16T11:21:35ZengWileyCancer Medicine2045-76342021-08-0110165395540410.1002/cam4.3573The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinomaCortlandt M. Sellers0Johannes Uhlig1Johannes M. Ludwig2Jeffrey S. Pollak3Tamar H. Taddei4Stacey M. Stein5Joseph K. Lim6Hyun S. Kim7Section of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USASection of Digestive Diseases Department of Internal Medicine Yale University School of Medicine New Haven CT USASection of Medical Oncology Department of Internal Medicine Yale University School of Medicine New Haven CT USASection of Digestive Diseases Department of Internal Medicine Yale University School of Medicine New Haven CT USASection of Interventional Radiology Department of Radiology and Biomedical Imaging Yale University School of Medicine New Haven CT USAAbstract Background Inflammation and the immune system significantly impact the development, progression, and treatment response of hepatocellular carcinoma (HCC). This retrospective study investigated the neutrophil‐to‐lymphocyte ratio (NLR) as a prognostic biomarker in Western patients with HCC in the setting of chronic viral hepatitis. Methods Patients diagnosed with HCC from 2005 to 2016 were selected from a tertiary care institution. NLR was calculated within 30 days prior to treatment and dichotomized at the median. Kaplan–Meier overall survival (OS) curves and Cox hazard proportional models were utilized. Tumor and liver reserve parameters were included in multivariable analyses (MVA). Results A total of 581 patients met inclusion criteria (median age 61.0 yr; 78.3% male; 66.3% Caucasian) with median OS = 34.9 mo. 371 patients (63.9%) had viral hepatitis, of which 350 had hepatitis C (94.3%). The low‐NLR group (<median NLR = 2.45) demonstrated higher median OS of 45.6 mo versus the high‐NLR group (median OS 23.9 mo, p < 0.0001). Log‐transformed NLR was associated with decreased OS, after multivariable adjustment for confounders (hazard ratio [HR] = 1.34, p = 0.0033). Viral hepatitis was identified as an NLR effect modifier: in nonviral hepatitis (n = 210), low NLR was associated with higher median OS versus high NLR (56.7 mo vs. 17.6 mo, p < 0.0001). This was decreased in viral hepatitis (n = 371) (low vs. high NLR: 41.9 mo vs. 35.2 mo, p = 0.0109). Further, the interaction term between hepatitis and log‐transformed NLR was significant (p = 0.0274) on MVA. Conclusions Lower baseline NLR was associated with increased overall survival in HCC. Viral hepatitis serves as an effect modifier of NLR, attenuating its prognostic relevance in this hepatitis C‐predominant population.https://doi.org/10.1002/cam4.3573hepatitis Ccarcinomahepatocellularinflammationneutrophilslymphocytes
collection DOAJ
language English
format Article
sources DOAJ
author Cortlandt M. Sellers
Johannes Uhlig
Johannes M. Ludwig
Jeffrey S. Pollak
Tamar H. Taddei
Stacey M. Stein
Joseph K. Lim
Hyun S. Kim
spellingShingle Cortlandt M. Sellers
Johannes Uhlig
Johannes M. Ludwig
Jeffrey S. Pollak
Tamar H. Taddei
Stacey M. Stein
Joseph K. Lim
Hyun S. Kim
The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
Cancer Medicine
hepatitis C
carcinoma
hepatocellular
inflammation
neutrophils
lymphocytes
author_facet Cortlandt M. Sellers
Johannes Uhlig
Johannes M. Ludwig
Jeffrey S. Pollak
Tamar H. Taddei
Stacey M. Stein
Joseph K. Lim
Hyun S. Kim
author_sort Cortlandt M. Sellers
title The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
title_short The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
title_full The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
title_fullStr The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
title_full_unstemmed The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
title_sort effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
publisher Wiley
series Cancer Medicine
issn 2045-7634
publishDate 2021-08-01
description Abstract Background Inflammation and the immune system significantly impact the development, progression, and treatment response of hepatocellular carcinoma (HCC). This retrospective study investigated the neutrophil‐to‐lymphocyte ratio (NLR) as a prognostic biomarker in Western patients with HCC in the setting of chronic viral hepatitis. Methods Patients diagnosed with HCC from 2005 to 2016 were selected from a tertiary care institution. NLR was calculated within 30 days prior to treatment and dichotomized at the median. Kaplan–Meier overall survival (OS) curves and Cox hazard proportional models were utilized. Tumor and liver reserve parameters were included in multivariable analyses (MVA). Results A total of 581 patients met inclusion criteria (median age 61.0 yr; 78.3% male; 66.3% Caucasian) with median OS = 34.9 mo. 371 patients (63.9%) had viral hepatitis, of which 350 had hepatitis C (94.3%). The low‐NLR group (<median NLR = 2.45) demonstrated higher median OS of 45.6 mo versus the high‐NLR group (median OS 23.9 mo, p < 0.0001). Log‐transformed NLR was associated with decreased OS, after multivariable adjustment for confounders (hazard ratio [HR] = 1.34, p = 0.0033). Viral hepatitis was identified as an NLR effect modifier: in nonviral hepatitis (n = 210), low NLR was associated with higher median OS versus high NLR (56.7 mo vs. 17.6 mo, p < 0.0001). This was decreased in viral hepatitis (n = 371) (low vs. high NLR: 41.9 mo vs. 35.2 mo, p = 0.0109). Further, the interaction term between hepatitis and log‐transformed NLR was significant (p = 0.0274) on MVA. Conclusions Lower baseline NLR was associated with increased overall survival in HCC. Viral hepatitis serves as an effect modifier of NLR, attenuating its prognostic relevance in this hepatitis C‐predominant population.
topic hepatitis C
carcinoma
hepatocellular
inflammation
neutrophils
lymphocytes
url https://doi.org/10.1002/cam4.3573
work_keys_str_mv AT cortlandtmsellers theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT johannesuhlig theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT johannesmludwig theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT jeffreyspollak theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT tamarhtaddei theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT staceymstein theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT josephklim theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT hyunskim theeffectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT cortlandtmsellers effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT johannesuhlig effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT johannesmludwig effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT jeffreyspollak effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT tamarhtaddei effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT staceymstein effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT josephklim effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
AT hyunskim effectofchronicviralhepatitisonprognosticvalueofinflammatorybiomarkersinhepatocellularcarcinoma
_version_ 1721205823442518016